Home
Guidelines
Pathogens
Antimicrobials
Medium
NA
$75/day
Infants and Children 30 mg/kg/day divided q12h (up to 500 mg/dose)
Adolescents 1000 mg IV q24h
1g IV q24h
Targeted therapy of ESBL infections and other resistant gram negative infections.
Empiric therapy when broad spectrum of carbapenems is desired without the need for anti-pseudomonal activity.
Immediate and delayed-type allergy
GI disturbance
Cytopenias, eosinophilia, positive Coombs
Liver enzyme abnormalities
Seizure risk lower than other carbapenems
Infectious Diseases Consultation required.
Antimicrobial class: Carbapenem
Pregnancy category: B
Average serum half life: 4 hours
Biliary penetration: Moderate
Lung penetration: Therapeutic
Urine penetration: Therapeutic